Summary
Rats injected i. p. with a single dose of nicotinamide (250 mg/kg) 15 min prior to i.v. injection of streptozotocin (65 mg/kg) develop a very mild form of diabetes characterized by slight elevations of plasma glucose, increased levels of HbA1, and reduced insulin secretion in response to an i.v. glucose tolerance test. These rats gain weight normally and they are not hyperphagic, glycosuric, or polyuric. The effects of this very mild form of diabetes vs overt streptozotocin diabetes of three months duration on regional vascular 131I-albumin clearance, blood flow (assessed by 15 μm 85Sr-microspheres), and renal filtration function were examined in male Sprague-Dawley rats. Plasma glucose levels of rats with mild diabetes were 7.4±0.9 (mean±SD) (mmol/l) vs 6.5±0.6 for control rats and 31.3±6.0 for overtly diabetic rats. HbA1 levels were increased 1.4 fold in mildly diabetic and 2.3 fold in overtly diabetic rats. Vascular clearance of 131I-albumin was markedly increased in ocular tissues (anterior uvea, retina, and choroid), sciatic nerve, aorta, new (subcutaneous) granulation tissue, and kidney of both diabetic groups, although increases in overtly diabetic rats exceeded those in the mildly diabetic group (2.2–4.6 times control animals vs 1.6–3.3 times, respectively). Likewise, both overt and very mild diabetes markedly increased glomerular filtration rate (∼1.8 times and 1.2 times control animals, respectively), urinary excretion of endogenous albumin (∼9 times and 4 times) and IgG (∼15 times and 4 times), as well as regional blood flow in the anterior uvea, choroid, and sciatic nerve. Increases in tissue sorbitol levels were much larger in overtly diabetic rats (generally 10–20 times control animals) than in mildly diabetic rats (1.5–3 times controls). myo-Inositol levels were significantly decreased only in lens and sciatic nerve of overtly diabetic rats. These observations indicate that even very mild diabetes is associated with vascular functional changes which develop more slowly than in overtly diabetic rats, but are disproportionately large (in view of the minimal increases in glycaemia and tissue polyol levels) compared to those in overtly diabetic rats.
Article PDF
Similar content being viewed by others
References
Caird FI, Pine A, Ramsei TG (1968) Diaibetes and the eye. Black-well, Oxford
Jarrett RJ, Keen H (1976) Hyperglycaemia and diabetes mellitus. Lancet II: 1009–1012
Pirart K (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188, 252–263
West KM (1978) Epidemiology of diabetes and its vascular lesions. Elsevier, New York, pp 402–439
Palmberg P, Smith M, Waltman S, Krupin T, Singer P, Burgess D, Wendtlant T, Achtenberg J, Cryer P, Santiago J, White N, Kilo C, Daughaday W (1981) The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 88: 613–618
Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, Nachazel DP Jr, Weiss H, Christopherson KW, Cronin MA (1982) Retinopathy in juvenile-onset Type 1 diabetes of short duration. Diabetes 31: 874–882
Ballard DJ, Melton LJ III, Dwyer MS, Trautmann JC, Chu C-P, O'Fallon WM, Palumbo PJ (1986) Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9: 334–342
Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ (1986) Prevalence of diabetic complications in relation to risk factors. Diabetes 35: 1332–1339
Krolewski AS, Warram JH, Rand LI, Christlieb AR, Busick EJ, Kahn CR (1986) Risk of proliferative diabetic retinopathy in juvenile-onset Type 1 diabetes: a 40-year follow-up study. Diabetes Care 9: 443–452
Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC (1986) Retinopathy in older Type 2 diabetics: association with glucose control. Diabetes 35: 797–801
Monson JP, Koios G, Toms GC, Kopelman PG, Boucher BJ, Evans SJW, Alexander WL (1986) Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetes. J Royal Soc Med 79: 274–276
Sterky G, Wall S (1986) Determinants of microangiopathy in growth-onset diabetes. Acta Paed Scand [Suppl] 327: 5–45
Weber B, Burger W, Hartmann R, Hovener G, Malchus R, Oberdisse U (1986) Risk factors for the development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 23–29
Klein BE, Moss SE, Klein R (1987) Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care 10: 273–277
Davis MD (1988) Diabetic retinopathy: a clinical overview. Diabetes Metab Rev 4: 291–322
Hanssen KF, Dahl-Jorgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: the near-normoglycaemic experience. Diabetologia 29: 677–684
Kamenetzky SA, Bennett PH, Dippe SE, Miller M, LeCompte PM (1974) A clinical and histological study of diabetic nephropathy in the Pima Indians. Diabetes 23: 61–68
Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT (1982) The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 21: 730–738
Viberti GC, Mackintosh D, Bilous RW, Pickup JC, Keen H (1982) Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int 21: 714–720
Holman RR, Dornan TL, Mayon-White V, Howard-Williams J, Orde-Peckar C, Jenkins L, Steemson J, Rolfe R, Smith B, Barbour D, McPherson K, Poon P, Rizza C, Mann JI, Knight AH, Bron AJ, Turner RC (1983) Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet I: 204–208
Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in Type 1 diabetes. Am J Med 78: 785–794
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet II: 1300–1304
Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T (1987) Declining incidence of persistent proteinuria in Type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 36: 205–209
Viberti G (1988) Etiology and prognostic significance of albuminuria in diabetes. Diabetes Care 11: 840–845
Graf RJ, Halter JB, Halar E, Porte D (1979) Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin. Ann Int Med 90: 298–303
Thomas PK, Eliasson SG (1984) Diabetic Neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy, Vol II. Saunders, Philadelphia, pp 1773–1810
Vinik A, Mitchell B (1988) Clinical aspects of diabetic neuropathies. Diab Metab Rev 4: 223–253
Freedman LR (1957) Inapparent diabetes mellitus as a cause of renal insufficiency due to Kimmelstiel-Wilson lesions. Bull Johns Hopkins Hosp 100: 132–138
Collens WS, Silverstein JN, Dobkin GB (1959) Case of a diabetic with a Kimmelstiel-Wilson syndrome and a normal glucose tolerance. Ann Int Med 50: 1282–1288
Ellenberg M (1963) Diabetic complications without manifest diabetes. JAMA 183: 926–930
Harrington AR, Hare HG, Chambers WN, Valtin H (1966) Nodular glomerulosclerosis suspected during life in a patient without demonstrable diabetes mellitus. N Engl J Med 275: 206–208
Strauss FG, Argy WP, Schreiner GE (1971) Diabetic glomerulosclerosis in the absence of glucose intolerance. Ann Int Med 75: 239–242
Harrington JT, Garella S, Stilmant MM, Chazan JA (1973) Renal failure as the initial manifestation of diabetes mellitus. Arch Intern Med 132: 249–251
Nash DA, Rogers PW, Langlinais PC, Bunn SM Jr (1975) Diabetic glomerulosclerosis without glucose intolerance. Am J Med 59: 191–199
Winaver J, Teredesai P, Feldman HA, Stachura I, Cavallo T, Puschett JB (1979) Diabetic nephropathy as the mode of presentation of diabetes mellitus. Metabolism 28: 1023–1030
Chan JYC, Cole E, Hanna AK (1985) Diabetic nephropathy and proliferative retinopathy with normal glucose tolerance. Diabetes Care 8: 385–390
Williamson JR, Tilton RG, Chang K, Kilo C (1988) Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. Diabetes Metab Rev 4: 339–370
Engerman RL, Kern TS (1984) Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33: 97–100
Kern TS, Engerman RL (1987) Kidney morphology in experimental hyperglycemia. Diabetes 36: 244–249
Frank RN, Keirn RJ, Kennedy A, Frank KW (1983) Galactose-induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci 24: 1519–1524
Chandler ML, Shannon WA, DeSantis L (1984) Prevention of retinal capillary basement membrane thickening in diabetic rats by aldose reductase inhibitors. Invest Ophthalmol Vis Sci 25 [Suppl]: 159 (Abstract)
Robison WG Jr, Kador PF, Akagi Y, Kinoshita JH, Gonzalez R, Dvornik D (1986) Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, Tolrestat. Diabetes 35: 295–299
Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR (1989) Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38: 1258–1270
Williamson JR, Chang K, Tilton RG, Allison W, Ashton T, Kilo C (1987) Increased ocular blood flow and 125I-albumin permeation in diabetic rats are aldose reductase-linked phenomena. Invest Ophthalmol Vis Sci 28: 69 (Abstract)
Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C (1987) Increased vascularpermeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes: prevention by aldose reductase inhibitors and castration. Diabetes 36: 813–821
Tilton RG, Chang K, Weigel C, Eades D, Sherman WR, Kilo C, Williamson JR (1988) Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by Sorbinil. Invest Ophthalmol Vis Sci 29: 861–868
Lazarow A, Liambies J, Tausch AJ (1950) Protection against diabetes with nicotinamide. J Lab Clin Med 36: 249–258
Schein PS, Cooney DA, Vernon ML (1967) The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. Cancer Res 27: 2324–2332
Dulin WE, Wyse BM (1969) Reversal of streptozotocin diabetes with nicotinamide. Proc Soc Exp Biol Med 130: 992–994
Stauffacher W, Burr I, Futzeit A, Beaven D, Veleminsky J, Renold AE (1970) Streptozotocin diabetes: time course of irreversible β-cell damage; further observations on prevention by nicotinamide. Proc Soc Exp Biol Med 133: 194–200
Lazarus SS, Shapiro SH (1973) Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic β cell cytotoxicity. Diabetes 22: 499–501
Wahlberg G, Carlson LA, Wasserman J, Ljungqvuist A (1985) Protective effect of nicotinamide against nephropathy in diabetic rats. Diabetes Res 2: 307–312
Kilzer P, Chang K, Marvel J, Rowold E, Jaudes P, Ullensvang S, Kilo C, Williamson JR (1985) Albumin permeation of new vessels is increased in diabetic rats. Diabetes 34: 333–336
Lowry OH, Passonneau JV (1972) A flexible system of enzymatic analysis. Academic Press, Orlando, p 174
McFarland KF, Catalano EW, Day JR, Thorpe SR, Baynes JW (1979) Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 28: 1011–1014
Tilton RG, Pugliese G, Chang K, Kilo C, Williamson JR (1989) Effects of hypothyroidism on vascular 125I-albumin permeation and blood flow in rats. Metabolism 38: 471–478
Krohn KA, Welch MJ (1974) Studies of radioiodinated fibrinogen. I. Lactoperoxidase iodination of fibrinogen and model compounds. Int J Appl Radiot Isot 25: 315–323
Kilzer P, Chang K, Marvel J, Kilo C, Williamson JR (1985) Tissue differences in vascular permeability changes induced by histamine. Microvasc Res 30: 270–285
Bridge JHE, Bersohn MM, Gonzalez F, Bassingthwaighte JB (1982) Synthesis and use of radiocobaltic EDTA as an extracellular marker in rabbit heart. Am J Physiol 242: 671–676
Williamson JR, Holmberg SW, Chang K, Marvel J, Sutera SP, Needleman P (1989) Mechanisms underlying atriopeptin-induced increases in hematocrit and vascular permeation in rats. Circ Res 64: 890–899
Bell DR, Pinter GG, Wilson PD (1978) Albumin permeability of the peritubular capillaries in rat renal cortex. J Physiol 279: 621–640
Wolgast M, Larson M, Nygren K (1981) Functional characteristics of the renal interstitium. Am J Physiol 241: F105-F111
Larson M, Sjoquist M, Wolgast M (1984) Renal interstitial volume of the rat kidney. Acta Physiol Scand 120: 297–304
Eades DM, Williamson JR, Sherman WR (1989) Rapid analysis of sorbitol, galactitol, mannitol and myo-inositol mixtures from biological sources. J Chromatography 490: 1–8
Tancrede G, Rousseau-Migneron S, Nadea A (1982) Beneficial effects of physical training in rats with a mild streptozotocin-induced diabetes mellitus. Diabetes 31: 406–409
Morgan CR, Lazarow A (1963) Immunoassay of insulin: two antibody system: plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes 12: 115–126
Hollander M, Wolfe D (1973) Nonparametric Statistical Methods. Wiley & Sons, New York
Cole IWL, Grizzle IE (1966) Applications of multivariate analysis of variance to repeated measures experiments. Biometrics 22: 810–828
Anderson TW (1958) An introduction to multivariate statistical analysis. Wiley & Sons, New York
Lehman EL (1975) Nonparametrics: statistical methods based on ranks. Holden-Day, San Francisco
Blom G (1958) Statistical estimates and transformed beta variables. Wiley & Sons, New York
Miller RG Jr (1981) Simultaneous statistical inference. Springer, Berlin Heidelberg New York
Mauer SM, Brown DM, Matas AJ, Steffes MW (1978) Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus. Diabetes 27: 959–964
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin. Invest 77: 1925–1930
Goldfarb S, Simmons DA, Kern EFO (1986) Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition. Transact Assoc Am Phys 99: 67–72
Feldt-Rasmussen B (1986) Increased transcapillary escape rate of albumin in Type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 29: 282–286
Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356–360
Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ (1984) Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med 1: 17–19
Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590–596
Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59: 750–755
Jacobson SH, Fryd D, Sutherland DER, Kjellstrand CM (1988) Treatment of the diabetic patient with end-stage renal failure. Diabetes Metab Rev 4: 191–200
Mogensen CE, Schmitz A, Christensen CK (1988) Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev 4: 453–483
Krupin T, Waltman SR (1985) Fluorophotometry in juvenile-onset diabetes: long-term follow-up. Jpn J Ophthalmol 29: 139–145
Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36: 383–388
Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA (1983) Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 32: 943–949
Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143–1155
Michels LD, O'Donnell MP, Keane WF (1984) Glomerular hemodynamic and structural correlations in long-term experimental diabetic rats. J Lab Clin Med 103: 840–847
Mogensen CE (1986) Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46: 201–206
Zatz R, Brenner BM (1986) Pathogenesis of diabetic microangiopathy: the hemodynamic view. Am J Med 80: 443–453
Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410–415
Jensen PK, Christiansen JS, Steven K, Parving H-H (1981) Renal function in streptozotocin-diabetic rats. Diabetologia 21: 409–414
Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM (1987) Elevated plasma arterial natriuretic peptide levels in diabetic rats. J Clin Invest 80: 670–674
Carbonell LF, Salom MG, Garcia-Estan J, Salazar FJ, Ubeda M, Quesada T (1987) Hemodynamic alterations in chronically conscious unrestrained diabetic rats. Am J Physiol 252: H900-H905
O'Donnell MP, Kasiske BL, Keane WF (1988) Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J 2: 2339–2347
Rosenstock J, Raskin P (1986) Early diabetic nephropathy: assessment and potential therapeutic interventions. Diabetes Care 9: 529–545
Kohner EM, Sharp PS (1987) Diabetic retinopathy. In: Alberti KGMM, Krall LP (eds) The diabetes annual/3. Elsevier Science, Amsterdam, pp 252–288
Mogensen CE (1987) Early diabetic renal involvement and nephropathy: can treatment modalities be predicted from identification of risk factors? In: Alberti KGMM, Krall LP (eds) The diabetes annual/3. Elsevier, Amsterdam, pp 306–324
Viberti G (1988) Recent advances in understanding mechanisms and natural history of diabetic renal disease. Diabetes Care 11 [Suppl 1]: 3–9
Mauer SM, Steffes MW, Azar S, Kupcho-Sandberg S, Brown DM (1978) The effect of Goldblatt hypertension on the development of glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738–744
Tilton RG, LaRose L, Prater C (1986) Additive effects of hypertension- and diabetes-induced increased albumin permeation in eyes, aorta, and kidney of rats. Diabetes 33: 164
Christiansen JS, Gammelgaard T, Tronier B, Svendsen PA, Parving H-H (1982) Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21: 683–688
Wiseman MJ, Saunders AJ, Keen H, Viberti GC (1985) Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312: 617–621
Michels LD, Davidman M, Keane WF (1981) Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Sci 98: 869–885
Jensen PK, Steven K, Blaehr H, Christiansen JS, Parving H-H (1986) Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495
Craven PA, Caines MA, DeRubertis FR (1987) Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes. Metabolism 36: 95–103
Jensen PK, Christiansen JS, Steven K, Parving H-H (1987) Strict metabolic control and renal function in the streptozotocin diabetic rat. Kidney Int 31: 47–51
Bowman RH, Maack T (1972) Glucose transport by the isolated perfused rat kidney. Am J Physiol 222: 1499–1504
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pugliese, G., Tilton, R.G., Speedy, A. et al. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats. Diabetologia 32, 845–857 (1989). https://doi.org/10.1007/BF00297449
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00297449